Dicerna Pharms, Inc. v. Alnylam Pharms, Inc.
(17-11466) (D. Mass) Represented Dicerna in antitrust litigation with its competitor Alnylam in the RNA interference field. Settled favorably for Dicerna.
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.